ClinicalTrials.gov
ClinicalTrials.gov Menu

Fetal Anomalies Scan at the Time of Nuchal Translucency Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00943189
Recruitment Status : Unknown
Verified November 2009 by Sheba Medical Center.
Recruitment status was:  Recruiting
First Posted : July 22, 2009
Last Update Posted : November 20, 2009
Sponsor:
Information provided by:
Sheba Medical Center

Brief Summary:
Purpose: Fetal anomalies scan at the time of Nuchal Translucency (NT) study.

Condition or disease
Fetal Anomalies

Detailed Description:
Prospective study of patients at 12-14 weeks gestation that are coming for NT examination is conducted. Meticulous ultrasound examination will be done to the fetuses using trans vaginal and transabdominal techniques. The patients will receive only the NT information. Only in cases of detection of severe fetal anomalies the patient will get the information of the examination and counseling according to the findings. All patients will be asked to provide information of the 15 weeks early comprehensive ultrasound examination. The NT examination will be compared to the 15 weeks ultrasound. All patients will be asked to give information after delivery of the baby's health condition.

Study Type : Observational
Estimated Enrollment : 600 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Fetal Anomalies Scan at the Time of Nuchal Translucency Study
Study Start Date : June 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Nuclear Scans
U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
All pregnant women at 12-14 weeks of gestation that are coming for nuchal translucency examination and willing to participate in the study.
Criteria

Inclusion Criteria:

  • pregnant women at 12-14 weeks

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00943189


Contacts
Contact: Liat Gindes, MD gindesl@smile.net.il

Locations
Israel
Sheba Medical Center Recruiting
Ramat Gan, Israel
Contact: Liat Gindes, MD       gindesl@smile.net.il   
Sponsors and Collaborators
Sheba Medical Center

Responsible Party: Dr. Liat Gindes, Sheba Medical Center
ClinicalTrials.gov Identifier: NCT00943189     History of Changes
Other Study ID Numbers: SHEBA-08-4934-LG-CTIL
First Posted: July 22, 2009    Key Record Dates
Last Update Posted: November 20, 2009
Last Verified: November 2009

Keywords provided by Sheba Medical Center:
Fetal anomalies scan at the time of NT study

Additional relevant MeSH terms:
Congenital Abnormalities